Titolo	Data di pubblicazione	Autore(i)
1	Variation of CD8+ T-lymphocytes around the bronchial internal perimeter in chronic bronchitis.	2003	E. GAMBLE; W. BURNS; J. ZHU; T. ANSARI; V. DE ROSE; J. KIPS; N.C. BARNES; P.K. JEFFERY
2	Variation in CD8+ T cell counts in the bronchial wall of subjects with chronic bronchitis.	2000	Gamble E; Zhu J; Ansari T; Oliva A; De Rose V; Barnes N; Jeffery P.
3	[Usefulness of chest X-ray during cystic fibrosis exacerbation in adult patients]	2001	CORTESE G ;NESPOLI P ;GROSSO B ;MESSORE B ;DE ROSE V ;FAVA C
4	[Use of aztreonam in the treatment of respiratory infections]	1985	GIALDRONI GRASSI G ; BRIGADA P ; DE ROSE V ; MANARA G ; MANGIAROTTI P ; GRASSI C
5	Tumor necrosis factor-alpha in airway secretions from cystic fibrosis patients upregulate endothelial adhesion molecules and induce airway epithelial cell apoptosis: implications for cystic fibrosis lung disease	2008	Mitola S; Sorbello V; Ponte E; Copreni E; Mascia C; Bardessono M; Goia M; Biasi F; Conese M; Poli G; Bussolino F; De Rose V.
6	Treatment of low bone density in young people with cystic fibrosis: a multicentre, prospective, open-label observational study of calcium and calcifediol followed by a randomised placebo-controlled trial of alendronate	2013	Bianchi ML; Colombo C; Assael BM; Dubini A; Lombardo M; Quattrucci S; Bella S; Collura M; Messore B; Raia V; Poli F; Bini R; Albanese CV; De Rose V; Costantini D; Romano G; Pustorino E; Magazzù G; Bertasi S; Lucidi V; Traverso G; Coruzzo A; Grzejdziak AD.
7	Tiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT trial.	2010	Troosters T, Celli B, Lystig T, Kesten S, Mehra S, Tashkin DP, Decramer M; Uplift Investigators including, De Rose V.
8	The Hermansky-Pudlak syndrome. A case with macrophage-neutrophil alveolitis.	1986	LUISETTI M ; FIOCCA R ; POZZI E ; DE ROSE V ; MAGRINI U ; GRASSI C
9	The effect of teicoplanin on leukocytic activity and intraleukocytic micro-organisms.	1986	FIETTA A ; BERSANI C ; DE ROSE V ; GRASSI FM ; GIALDRONI GRASSI G
10	The clinical role of BAL in idiopathic pulmonary fibrosis.	1990	HASLAM PL ;POULTER LW ;ROSSI GA ;BAUER W ;DE ROSE V ;ECKERT H ;OLIVIERI D ;TESCHLER H
11	Substance P increases neutrophil adhesion to bronchial epithelial cells.	1992	De Rose V; Robbins RA; Snider RM; Spurzem JR; Thiele GM; Rennard SI; Pozzi E; Rubinstein I
12	Substance P increases neutrophil adhesion to bronchial epithelial cells	1994	V. DE ROSE; R.A. ROBBINS; R.M. SNIDER; J.R. SPURZEM; G.M. THIELE; S.I. RENNARD; I. RUBINSTEIN
13	[Study of aspecific bronchial reactivity in subjects with allergic diseases and in bronchial asthma patients]	1980	RICCA M ; CERRETELLI N ; DE ROSE V ; FRANZIN A
14	STRATEGIES IN THE PHARMACOLOGIC PREVENTION OF LUNG EMPHYSEMA.	1990	POZZI E; V. DE ROSE; LUISETTI M.
15	La semeiotica dell’Apparato Respiratorio	2008	Messore B; De Rose V
16	Roxithromycin (RU 28965) in the treatment of respiratory tract infections.	1987	GRASSI C ; BERTOLETTI R ; DE ROSE V ; MANARA G ; MANGIAROTTI P
17	Role of chest radiography in the diagnosis of allergic bronchopulmonary aspergillosis in adult patients with cystic fibrosis.	2007	CORTESE G; MALFITANA V; PLACIDO R; FERRARI A; GROSSO B; V. DE ROSE; NESPOLI P; FAVA C
18	Release of prostaglandin E2 and leukotriene B4 by alveolar macrophages from patients with sarcoidosis.	1997	DE ROSE V.; TRENTIN L.; CRIVELLARI M.T.; CIPRIANI A.; GIALDRONI GRASSI G.; POZZI E.; FOLCO G.; SEMENZATO G.
19	Relationship between total inflammatory cell number and lung function in large and small airways.	1995	Kim HK; Ansari T; Gizycki MJ; Oliva A; Valobra M; De Rose V; Jeffery PK.
20	Recurrent exacerbations affect FEV(1) decline in adult patients with cystic fibrosis	2008	Amadori A; Antonelli A; Balteri I; Schreiber A; Bugiani M; De Rose V.